A carregar...
Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use
Pirfenidone (Esbriet(®)) is available as capsules containing 267 mg of pirfenidone and, more recently, as bioequivalent tablets containing 267, 534 or 801 mg of pirfenidone. Both formulations are indicated to treat idiopathic pulmonary fibrosis (IPF), with pirfenidone being shown to generally reduce...
Na minha lista:
| Publicado no: | Drugs Ther Perspect |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6019423/ https://ncbi.nlm.nih.gov/pubmed/30008572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40267-017-0459-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|